These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 16010849

  • 1. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S, Okutomi T, Ohtsuka K, Hoshiko S, Uchida K, Yamaguchi H.
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents.
    Salama SM, Atwal H, Gandhi A, Simon J, Poglod M, Montaseri H, Khan JK, Furukawa T, Saito H, Nishida K, Higashitani F, Uji T, Unemi N, Daneshtalab M, Micetich RG.
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2420-6. PubMed ID: 11502508
    [Abstract] [Full Text] [Related]

  • 3. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F, Schimizzi AM, Caselli F, Novelli A, Fallani S, Giannini D, Arzeni D, Di Cesare S, Di Francesco LF, Fortuna M, Giacometti A, Carle F, Mazzei T, Scalise G.
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [Abstract] [Full Text] [Related]

  • 4. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J, Li S, Gao A, Zhu K, Zhang H.
    Phytomedicine; 2018 Jul 15; 46():21-31. PubMed ID: 30097119
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.
    Tsuchimori N, Hayashi R, Kitamoto N, Asai K, Kitazaki T, Iizawa Y, Itoh K, Okonogi K.
    Antimicrob Agents Chemother; 2002 May 15; 46(5):1388-93. PubMed ID: 11959573
    [Abstract] [Full Text] [Related]

  • 6. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
    Sun L, Liao K, Hang C.
    Phytomedicine; 2018 Feb 01; 40():55-58. PubMed ID: 29496175
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
    Kamai Y, Harasaki T, Fukuoka T, Ohya S, Uchida K, Yamaguchi H, Kuwahara S.
    Antimicrob Agents Chemother; 2002 Feb 01; 46(2):367-70. PubMed ID: 11796343
    [Abstract] [Full Text] [Related]

  • 8. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
    Lu Y, Zhou Z, Mo L, Guo Q, Peng X, Hu T, Zhou X, Ren B, Xu X.
    Appl Microbiol Biotechnol; 2019 Aug 01; 103(16):6701-6709. PubMed ID: 31201451
    [Abstract] [Full Text] [Related]

  • 9. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M, Yan H, Lu M, Wang D, Sun S.
    Int J Antimicrob Agents; 2020 Jan 01; 55(1):105804. PubMed ID: 31605727
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
    Hata K, Kimura J, Miki H, Toyosawa T, Nakamura T, Katsu K.
    Antimicrob Agents Chemother; 1996 Oct 01; 40(10):2237-42. PubMed ID: 8891121
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA, Lone SA, Gull P, Dar OA, Wani MY, Ahmad A, Hashmi AA.
    Med Chem; 2019 Oct 01; 15(6):648-658. PubMed ID: 30501599
    [Abstract] [Full Text] [Related]

  • 12. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y, Ren H, Wang D, Zhang M, Sun S, Zhao Y.
    Biomed Pharmacother; 2020 Oct 01; 130():110580. PubMed ID: 32745913
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.
    Elizondo-Zertuche M, Robledo-Leal E, González JG, Ceceñas LA, González GM.
    Rev Iberoam Micol; 2015 Oct 01; 32(1):30-3. PubMed ID: 24071640
    [Abstract] [Full Text] [Related]

  • 14. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
    Najvar LK, Correa A, James P, Luther MF, Graybill JR.
    J Antimicrob Chemother; 1996 Oct 01; 38(4):671-7. PubMed ID: 8937961
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
    Niwano Y, Kuzuhara N, Goto Y, Munechika Y, Kodama H, Kanai K, Yoshida M, Miyazaki T, Yamaguchi H.
    Int J Antimicrob Agents; 1999 Aug 01; 12(3):221-8. PubMed ID: 10461840
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
    de Sá NP, de Paula LFJ, Lopes LFF, Cruz LIB, Matos TTS, Lino CI, de Oliveira RB, de Souza-Fagundes EM, Fuchs BB, Mylonakis E, Johann S.
    J Glob Antimicrob Resist; 2018 Sep 01; 14():287-293. PubMed ID: 29715565
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent.
    Zhao JX, Cao YY, Quan H, Liu CM, He QQ, Wu QY, Gao PH, Cao YB, Liu WX, Jiang YY.
    Biol Pharm Bull; 2006 Oct 01; 29(10):2031-4. PubMed ID: 17015946
    [Abstract] [Full Text] [Related]

  • 18. A combination approach to treating fungal infections.
    Shrestha SK, Fosso MY, Garneau-Tsodikova S.
    Sci Rep; 2015 Nov 23; 5():17070. PubMed ID: 26594050
    [Abstract] [Full Text] [Related]

  • 19. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
    Yang HC, Mikami Y, Yazawa K, Taguchi H, Nishimura K, Miyaji M, Branchini ML, Aoki FH, Yamamoto K.
    Mycoses; 1998 Dec 23; 41(11-12):477-80. PubMed ID: 9919890
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K, Kimura J, Miki H, Toyosawa T, Moriyama M, Katsu K.
    Antimicrob Agents Chemother; 1996 Oct 23; 40(10):2243-7. PubMed ID: 8891122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.